Cover Image

Serum concentration of selected angiogenesis-related molecules differs among molecular subtypes, body mass index and menopausal status in breast cancer patients

Background: Angiogenesis is a hallmark of breast cancer (BC) and is mediated by the vascular endothelial growth factor (VEGF) signaling axis. It is regulated by different proangiogenic factors, including platelet-derived growth factor-CC (PDGF-CC) and heparin-binding EGF-like growth factor (HB-EGF),...

Full description

Saved in:
Bibliographic Details
Main Authors: Balalis, Dimitrios (Author) , Tsakogiannis, Dimitrios (Author) , Kalogera, Eleni (Author) , Kokkali, Stefania (Author) , Tripodaki, Elli (Author) , Ardavanis, Alexandros (Author) , Manatakis, Dimitrios (Author) , Dimas, Dionysios (Author) , Koufopoulos, Nektarios (Author) , Fostira, Florentia (Author) , Korkolis, Dimitrios (Author) , Misitzis, Ioannis (Author) , Vassos, Nikolaos (Author) , Spiliopoulou, Chara (Author) , Vlachodimitropoulos, Dimitrios (Author) , Bletsa, Garyfalia (Author) , Arkadopoulos, Nikolaos (Author)
Format: Article (Journal)
Language:English
Published: 14 July 2022
In: Journal of Clinical Medicine
Year: 2022, Volume: 11, Issue: 14, Pages: 1-13
ISSN:2077-0383
DOI:10.3390/jcm11144079
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/jcm11144079
Verlag, kostenfrei, Volltext: https://www.mdpi.com/2077-0383/11/14/4079
Get full text
Author Notes:Dimitrios Balalis, Dimitrios Tsakogiannis, Eleni Kalogera, Stefania Kokkali, Elli Tripodaki, Alexandros Ardavanis, Dimitrios Manatakis, Dionysios Dimas, Nektarios Koufopoulos, Florentia Fostira, Dimitrios Korkolis, Ioannis Misitzis, Nikolaos Vassos, Chara Spiliopoulou, Dimitrios Vlachodimitropoulos, Garyfalia Bletsa and Nikolaos Arkadopoulos
Description
Summary:Background: Angiogenesis is a hallmark of breast cancer (BC) and is mediated by the vascular endothelial growth factor (VEGF) signaling axis. It is regulated by different proangiogenic factors, including platelet-derived growth factor-CC (PDGF-CC) and heparin-binding EGF-like growth factor (HB-EGF), as well as co-receptors, such as neuropilin-1, which could have prognostic implications in BC patients. Patients and methods: We assessed the serum levels of VEGF, HB-EGF, PDGF-CC and neuropilin-1 in 205 patients with early BC (invasive, n = 187; in situ, n = 18) and in 31 healthy donors (HD) and investigated the potential associations with clinical and histopathological parameters. Results: VEGF serum levels were significantly higher in patients with invasive versus ductal carcinomas in situ. PDGF-CC serum concentrations varied among BC molecular subtypes. Furthermore, we observed a differential expression of most biomarkers between overweight/obese (body mass index (BMI) ≥ 25 kg/m2) and non-obese patients among the BC molecular subtypes. Finally, the classification of subjects according to menopausal status revealed a significant difference in specific biomarker levels between patients and HD. Conclusion: The serum concentrations of angiogenic molecules differ among breast cancer molecular subtypes and are affected by the BMI and menopausal status, which could have possible clinical or prognostic implications.
Item Description:Gesehen am 14.11.2023
Physical Description:Online Resource
ISSN:2077-0383
DOI:10.3390/jcm11144079

Similar Items